APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 41 filers reported holding APREA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | -42.3% | 19,664 | +42.1% | 0.00% | -50.0% |
| Q1 2022 | $26,000 | -78.3% | 13,835 | -67.0% | 0.00% | -83.3% |
| Q4 2021 | $120,000 | -40.3% | 41,955 | +2.0% | 0.01% | -40.0% |
| Q2 2021 | $201,000 | +279.2% | 41,142 | +292.9% | 0.02% | +400.0% |
| Q1 2021 | $53,000 | -55.1% | 10,471 | -56.4% | 0.00% | -69.2% |
| Q4 2020 | $118,000 | – | 24,029 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 48,819 | $36,000 | 0.01% |
| Quantamental Technologies LLC | 11,352 | $9,000 | 0.00% |
| Virtu Financial LLC | 19,664 | $15,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 45,000 | $33,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 47,362 | $36,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 5,000 | $4,000 | 0.00% |
| MORGAN STANLEY | 351,836 | $264,000 | 0.00% |
| BlackRock Inc. | 186,779 | $140,000 | 0.00% |
| Bank of New York Mellon Corp | 16,643 | $12,000 | 0.00% |
| Blackstone Inc. | 16,590 | $12,000 | 0.00% |